These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9532824)

  • 1. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E and dapsone-induced hemolysis.
    Kelly JW; Scott J; Sandland M; Van der Weyden MB; Marks R
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 11. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):318-27. PubMed ID: 12035293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage studies in untreated and treated leprosy patients.
    Gandhi G; Singh B
    Mutagenesis; 2004 Nov; 19(6):483-8. PubMed ID: 15548761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone hypersensitivity syndrome among leprosy patients in China.
    Tian W; Shen J; Zhou M; Yan L; Zhang G
    Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S; Karthikeyan S; Ramu G
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E and dapsone-induced hemolysis.
    Smith KC
    CMAJ; 1994 Jan; 150(2):128. PubMed ID: 8287332
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
    Arunthathi S; Raju S
    Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.